Canaccord Genuity Issues an Upgrade on Quidel (NASDAQ:QDEL) Shares. What’s Next?

July 18, 2017 - By Henry Gaston

  Canaccord Genuity Issues an Upgrade on Quidel (NASDAQ:QDEL) Shares. What’s Next?

Investors sentiment decreased to 0.8 in 2016 Q4. Its down 0.31, from 1.11 in 2016Q3. It is negative, as 8 investors sold Quidel Corporation shares while 36 reduced holdings. 8 funds opened positions while 27 raised stakes. 29.80 million shares or 0.16% less from 29.85 million shares in 2016Q3 were reported.

The New York-based Alliancebernstein L P has invested 0% in Quidel Corporation (NASDAQ:QDEL). Bnp Paribas Arbitrage invested in 0% or 869 shares. Barclays Public Ltd Company has 0% invested in Quidel Corporation (NASDAQ:QDEL). Price T Rowe Assocs Md has 2.66 million shares. Tiaa Cref Investment Mgmt Ltd Liability Company holds 0% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 103,235 shares. Nationwide Fund Advisors holds 208,245 shares or 0.02% of its portfolio. Ny State Common Retirement Fund stated it has 0.03% of its portfolio in Quidel Corporation (NASDAQ:QDEL). Royal Bancorporation Of Canada holds 1,875 shares or 0% of its portfolio. Blackrock Institutional Trust Na invested 0% in Quidel Corporation (NASDAQ:QDEL). 393,393 were accumulated by D E Shaw & Inc. Parametric Portfolio Associate Ltd Llc, Washington-based fund reported 45,355 shares. Great West Life Assurance Com Can invested in 0% or 1,767 shares. Rhumbline Advisers invested 0% in Quidel Corporation (NASDAQ:QDEL). Deutsche National Bank & Trust Ag holds 0% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 28,414 shares. Renaissance Tech Ltd Liability holds 0.02% in Quidel Corporation (NASDAQ:QDEL) or 502,200 shares.

Since February 24, 2017, it had 0 buys, and 4 sales for $5.07 million activity. Another trade for 37,080 shares valued at $834,204 was made by BRYANT DOUGLAS C on Wednesday, March 29. Shares for $1.05M were sold by Bujarski Robert Joseph.

Quidel (NASDAQ:QDEL) Stock Upgrade

Canaccord Genuity raised the shares of Quidel (NASDAQ:QDEL) from a Hold rating to Buy rating in an analyst note revealed to clients on Tuesday morning.

Investors sentiment decreased to 0.8 in 2016 Q4. Its down 0.31, from 1.11 in 2016Q3. It is negative, as 8 investors sold Quidel Corporation shares while 36 reduced holdings. 8 funds opened positions while 27 raised stakes. 29.80 million shares or 0.16% less from 29.85 million shares in 2016Q3 were reported.

The New York-based Alliancebernstein L P has invested 0% in Quidel Corporation (NASDAQ:QDEL). Bnp Paribas Arbitrage invested in 0% or 869 shares. Barclays Public Ltd Company has 0% invested in Quidel Corporation (NASDAQ:QDEL). Price T Rowe Assocs Md has 2.66 million shares. Tiaa Cref Investment Mgmt Ltd Liability Company holds 0% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 103,235 shares. Nationwide Fund Advisors holds 208,245 shares or 0.02% of its portfolio. Ny State Common Retirement Fund stated it has 0.03% of its portfolio in Quidel Corporation (NASDAQ:QDEL). Royal Bancorporation Of Canada holds 1,875 shares or 0% of its portfolio. Blackrock Institutional Trust Na invested 0% in Quidel Corporation (NASDAQ:QDEL). 393,393 were accumulated by D E Shaw & Inc. Parametric Portfolio Associate Ltd Llc, Washington-based fund reported 45,355 shares. Great West Life Assurance Com Can invested in 0% or 1,767 shares. Rhumbline Advisers invested 0% in Quidel Corporation (NASDAQ:QDEL). Deutsche National Bank & Trust Ag holds 0% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 28,414 shares. Renaissance Tech Ltd Liability holds 0.02% in Quidel Corporation (NASDAQ:QDEL) or 502,200 shares.

Since February 24, 2017, it had 0 buys, and 4 sales for $5.07 million activity. Another trade for 37,080 shares valued at $834,204 was made by BRYANT DOUGLAS C on Wednesday, March 29. Shares for $1.05M were sold by Bujarski Robert Joseph.

Quidel Corporation (NASDAQ:QDEL) Ratings Coverage

Among 8 analysts covering Quidel (NASDAQ:QDEL), 4 have Buy rating, 0 Sell and 4 Hold. Therefore 50% are positive. Quidel has $28.0 highest and $16 lowest target. $19.25’s average target is -46.36% below currents $35.89 stock price. Quidel had 15 analyst reports since September 2, 2015 according to SRatingsIntel. The stock has “Hold” rating by Canaccord Genuity on Tuesday, February 9. As per Friday, January 8, the company rating was maintained by Canaccord Genuity. The stock of Quidel Corporation (NASDAQ:QDEL) has “Mkt Perform” rating given on Monday, December 14 by Raymond James. The stock of Quidel Corporation (NASDAQ:QDEL) has “Outperform” rating given on Monday, June 13 by Raymond James. The stock has “Outperform” rating by William Blair on Tuesday, July 18. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, July 18. The firm earned “Neutral” rating on Friday, December 16 by Piper Jaffray. The stock of Quidel Corporation (NASDAQ:QDEL) has “Neutral” rating given on Friday, February 17 by CL King. The firm has “Hold” rating given on Friday, October 23 by Craig Hallum. The stock has “Overweight” rating by Barclays Capital on Wednesday, September 2.

About 3,355 shares traded. Quidel Corporation (NASDAQ:QDEL) has risen 56.78% since July 18, 2016 and is uptrending. It has outperformed by 40.08% the S&P500.

Wall Street await Quidel Corporation (NASDAQ:QDEL) to release earnings on July, 26. Analysts forecast EPS of $-0.17, down exactly $0.02 or 13.33 % from 2014’s $-0.15 EPS. After posting $0.42 EPS for the previous quarter, Quidel Corporation’s analysts now forecast -140.48 % negative EPS growth.

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The company has market cap of $1.42 billion. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. It has a 332.55 P/E ratio. The Firm sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

More notable recent Quidel Corporation (NASDAQ:QDEL) news were published by: Benzinga.com which released: “Mid-Afternoon Market Update: Peregrine Pharma Drops After Q4 Results; Quidel …” on July 17, 2017, also Streetinsider.com with their article: “Quidel Corp (QDEL) Reports Acquisition of Alere Triage Assets” published on July 17, 2017, Businesswire.com published: “Quidel to Hold Second Quarter 2017 Financial Results Conference Call on July …” on July 14, 2017. More interesting news about Quidel Corporation (NASDAQ:QDEL) were released by: Zacks.com and their article: “Quidel (QDEL) Worth a Look: Stock Jumps 25.4% in Session July 18, 2017” published on July 18, 2017 as well as Benzinga.com‘s news article titled: “Wall Street’s M&A Chatter From July 17: BorgWarner-Sevcon, Church & Dwight …” with publication date: July 18, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.